Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform (CYBRID-02)

NCT#:NCT05520099
NCT QR Code
Title:Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform (CYBRID-02)
Protocol:CYBRID-02
Cancer Type:multiple
Study Sponsor:Elephas
Brief Summary:The primary objective of this study is to determine the ex-vivo prognostic accuracy of the Cybrid live tumor diagnostic platform across a basket of solid tumors, using in-vivo RECIST 1.1 as the reference method.
Study Type:Intervention/Treatment
Date Opened at SVH:February 21, 2024
Recruitment Status:Recruiting
Study Population:See SCHEMA
Eligibility Criteria:See SCHEMA
Principal Investigators:Geetha N. Varma, MD, Oncology, Salinas Valley Health Cancer Care, (831) 755-1701
Hong Zhao, MD, Oncology, Salinas Valley Health Cancer Care, (831) 755-1701
Participating Institution:Salinas Valley Health
Salinas Valley Health Clinical Research Program:Terri Nielsen, MSJ, RN, CCRP, Clinical Research Program Manager, [email protected]
Link to ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT05520099?term=elephas%20cybrid&rank=2
SummarySee Patient-Facing Material